FDA Orange Book
Is there a generic for Nouress?
Nouress contains cysteine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Nouress (cysteine). The Orange Book shows its last listed patent expires March 15, 2039.
Run it in Rivvi
Map Nouress and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Nouress products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intravenous | 500MG/10ML (50MG/ML) | Marketed (Rx) | None | 0 | None |
NDA 212535, held by BAXTER HEALTHCARE CORP. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Nouress patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10478453 | January 15, 2039 | Drug product | U-2752 | 212535 |
| 10583155 | January 15, 2039 | Drug product | U-2752 | 212535 |
| 11510942 | January 15, 2039 | Drug product | U-2752 | 212535 |
| 11826383 | January 15, 2039 | Drug product | None | 212535 |
| 10905714 | January 15, 2039 | Drug product | None | 212535 |
| 11642370 | January 15, 2039 | Drug product | None | 212535 |
| 10918662 | January 15, 2039 | Drug product | None | 212535 |
| 12569514 | January 15, 2039 | Drug product | None | 212535 |
| 11648262 | January 15, 2039 | Drug product | None | 212535 |
| 11679125 | January 15, 2039 | Drug product | None | 212535 |
| 10653719 | January 15, 2039 | Drug product | None | 212535 |
| 10912795 | January 15, 2039 | Drug product | None | 212535 |
| 10933089 | January 15, 2039 | Drug product | None | 212535 |
| 10905713 | January 15, 2039 | Drug product | None | 212535 |
| 11684636 | January 15, 2039 | Drug product | None | 212535 |
| 11510941 | March 2, 2039 | Drug product | None | 212535 |
| 10543186 | March 15, 2039 | Method of use | U-2722 | 212535 |
| 11045438 | March 15, 2039 | Drug product | None | 212535 |
| 10493051 | March 15, 2039 | Drug product | None | 212535 |
| 10702490 | March 15, 2039 | Drug product | None | 212535 |
Nouress NDC codes
Questions
Is there a generic for Nouress?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Nouress (cysteine). The Orange Book shows its last listed patent expires March 15, 2039.
What is the generic name for Nouress?
The active ingredient in Nouress is cysteine, per the FDA Orange Book.
When does the Nouress patent expire?
The last patent listed for Nouress in the Orange Book expires March 15, 2039. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.